The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...

Genprex received approval to proceed to the highest dose in the Phase I Acclaim-3 trial of Reqorsa for ES-small cell lung ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

NovoCure’s Optune Lua, a wearable indicated for patients with metastatic non-small cell lung cancer has received approval ...

Airway Therapeutics is to launch a Phase III trial of zelpultide alfa, a drug to prevent bronchopulmonary dysplasia in ...

The highest mortality rate due to breast cancer in the US is seen in black women and the lowest in Asian American Pacific ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) expects the new UK clinical trial regulation to be ...

The upcoming two-day event delves into the clinical trial landscape and the strategies employed to increase the region’s ...